Pharmafile Logo
Pharmafocus logo
Advanced Search

Are patients about to take charge?

December 18, 2006
Medical Communications, Sales and Marketing NHS, healthcare, information, patients

While debate rages about many aspects of the pharmaceutical industry, one thing is agreed: our world is becoming ever-more patient-centred. …

Feature

Confidence in UK medicine safety high

December 15, 2006

After heavy criticism of UK medicines regulator the MHRA last year, a new survey found there is widespread confidence in …

News

Tycerb in landmark cancer trial

December 15, 2006
Sales and Marketing

GlaxoSmithKline's Tycerb has entered a landmark global trial in the treatment of aggressive breast cancer.This will be the first phase …

News

Merck outlines turnaround strategy

December 15, 2006
Sales and Marketing

Merck's battle to regain profitability and bring new life to its product pipeline is gathering momentum as its unprecedented reorganisation …

News

Birmingham hospital merger to be first of many

December 15, 2006

Debt-ridden Good Hope hospital trust is set to merge with one of the country's best hospitals, the neighbouring Heart of …

News

Government unveils plans for improved patient involvement

December 14, 2006

The views of patients in local healthcare decision making is to be further enhanced by the creation of Local Involvement …

News

Chance missed to reform NHS finance controls, say managers

December 11, 2006

A controversial NHS accounting system, in which in-debt trusts are penalised with budget cuts, will continue, despite protests from health …

News

National cancer network underpins prostate vaccine trial

December 11, 2006
Research and Development

The UK's National Cancer Research Network has given its backing to a phase IIb trial of a promising vaccine for …

News

GSK buys antibody firm Domantis for

December 11, 2006
Research and Development

GlaxoSmithKline has bought Cambridge-based antibody firm Domantis for £230 million.Domantis, a leader in developing the next generation of antibody therapies, …

News

Is optimisation the new sales mantra?

December 11, 2006
Sales and Marketing NHS, sales, strategy

The pharmaceutical industry still refuses to fall out of love with large sales forces, but there are signs beginning to …

Feature

TroVax a step nearer to orphan status

December 8, 2006
Research and Development

Oxford BioMedica's leading cancer immunotherapy vaccine has received a positive opinion as an orphan drug for renal cancer from the …

News

Closer scrutiny for high-risk clinical trials

December 8, 2006
Research and Development

Wide-ranging changes will be made to the way clinical trials are conducted in the UK following the final report by …

News

New UK body to fast-track breakthrough research

December 8, 2006
Research and Development

Faster approval of NHS clinical trials and NICE recommendations are almost certain following a fundamental shake-up in the way UK …

News

Novartis readies Prexige for European launch

December 8, 2006
Research and Development, Sales and Marketing

Novartis will launch Prexige in its first European markets outside the UK next year following its EMEA approval for osteoarthritic …

News

UK uptake of new medicines ‘about right’ say doctors

December 7, 2006
Sales and Marketing

Most UK doctors think the uptake of new medicines in the country is 'about right' according to a new survey …

News

Get the best from your R&D team

December 6, 2006
Business Services, Research and Development R&D, recruitment

One of the key drivers of much of the recent merger and acquisition activity within the pharmaceutical industry is the …

Feature

New treatment for patients resistant to cancer drug Glivec

December 6, 2006
Sales and Marketing

The first effective option for chronic myeloid leukaemia (CML) patients resistant or intolerant to prior treatment with Glivec has been …

News

Smoking cessation drug launched

December 5, 2006
Sales and Marketing

Champix, Pfizer's potential blockbuster smoking cessation drug, has been launched in the UK.This first-in-class treatment is designed to activate the …

News

PAN Advertising sold to marketing services group Creston

December 5, 2006
Medical Communications

One of the UK's last independent healthcare advertising agencies, PAN Advertising, has been sold to marketing services group Creston.Set up …

News

Cholesterol drug failure hits Pfizer

December 4, 2006
Research and Development, Sales and Marketing

Pfizer has suffered a major blow with its decision to cancel late-stage pipeline torcetrapib following safety concerns.Torcetrapib, which raises 'good' …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026